Learn More
Bio X Cell anti-human CTLA-4, Human IgG1, Ipilimumab, 5 MG
Supplier: Bio X Cell SIM0004R005MG
This non-therapeutic biosimilar antibody utilizes the same variable regions as the therapeutic antibody Ipilimumab. It is suitable for research use and reacts with human CTLA-4 (cytotoxic T lymphocyte antigen-4), also known as CD152.
- Target: Human CTLA-4 (CD152)
- Host: Human
- Species reactivity: Human
- Isotype: Human IgG1
- Purification: Protein A from animal-free facility
- Purity: ≥95% (SDS-PAGE); aggregation <5% (SEC); endotoxin ≤0.5EU/mg
- Reported applications: In vitro and in vivo CTLA-4 neutralization, Flow Cytometry, ELISA, Western Blot
- Formulation: PBS, pH 7.0; contains no stabilizers or preservatives
- Storage: Store at stock concentration at 4°C; do not freeze
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.